PTPRT and PTPRD Deleterious Mutations and Deletion Predict Bevacizumab Resistance in Metastatic Colorectal Cancer Patients.
Hung-Chih HsuNina LapkeShu-Jen ChenYen-Jung LuRen-Shiang JhouChien-Yuh YehWen-Sy TsaiHsin-Yuan HungJason Chia-Hsun HsiehTsai-Sheng YangTan Kien ThiamJeng-Fu YouPublished in: Cancers (2018)
Deleterious alterations in PTPRT/PTPRD are potential biomarkers for bevacizumab resistance.